This page is not intended
for U.S. audiences.
Driving innovation for the multiple myeloma community
Driving innovation for the multiple myeloma community
Target the Future is a global initiative dedicated to advancing innovation and addressing key needs in the multiple myeloma community. The programme provides education on progress in the field of multiple myeloma, identifies key challenges the community faces, and facilitates solutions to create a better future for patients, their caregivers and loved ones.
The Target the Future Think Tank Challenge issues a call for entries for ideas to create a better future for the multiple myeloma community. Funding of £85,000 (approximately $100,000) is awarded to the strongest proposal to help bring the idea to life.
2023 Target the Future Think Tank Challenge Grantee
Congratulations to the grantee of the Target the Future Think Tank Challenge - Cancer Support Community's Multiple Myeloma Digital Engagement Program!
- The programme focuses on empowering historically underserved and under-resourced multiple myeloma patients and their providers to ensure they are benefitting from the best possible care.
- The platform was designed to make easily available to patients and their loved ones vital resources and help bridge the digital health divide for those impacted people who don't have internet access.
The platform is currently customised to five pilot locations, including: San Francisco Bay Area, Los Angeles, Twin Cities, Arizona and Breckinridge County, Kentucky. The app, which provides a range of tools and resources in one platform, includes access to telehealth services, direct communication with a patient's care team, myeloma education, mental wellness resources, and more.
A Patient Out of Patience: Adversity Turns to Advocacy for First Think Tank Challenge Grant Recipient
2022 Target the Future Think Tank Challenge Grantee
Congratulations to the grantee of the Target the Future Think Tank Challenge – the HealthTree Equity and Diversity for Multiple Myeloma Program!
The programme focuses on broadening reach to educate and support myeloma patients and ensure all patients are given equal opportunity for excellent care, by:
HealthTree Foundation
Jenny Ahlstrom, HealthTree Foundation Founder and CEO and multiple myeloma patient
Valarie Traynham, HealthTree Foundation Coach and multiple myeloma patient
Ana Sahagun, HealthTree Foundation Patient Experience Manager
- Helping patients understand their treatment options, including clinical trials
- Aiding patients in the search for a multiple myeloma specialist
- Supporting patients emotionally (via one-on-one sessions and in groups)
- Addressing disparities for key ethnic groups (African Americans and Hispanics) and other underserved communities
Target the Future updates
Target the Future Think Tank Challenge launches with goal of reducing disparities in multiple myeloma (15 Mar 2023)
GSK selects Target the Future grant recipient in innovation challenge supporting multiple myeloma community (29 June 2022)
GSK unveils Target the Future, a global, multi-year programme to help address key challenges affecting the multiple myeloma community (1 Dec 2021)
Target the Future in the news
The Medicine Maker | 22 September 2022
Diversifying multiple myeloma care
visit >PharmaShots | 14 September 2022
Tania Small, VP, Global Medical Oncology Head, GSK, shares insights on Target the Future Think Tank Challenge
visit >Empowered Patient | 10 August 2022
Driving advancements in the treatment of multiple myeloma with Dr. Tania Small GSK
visit >Empowered Patient | 10 August 2022
Multiple myeloma patient advocates winner of GSK Target the Future Think Tank Challenge with Jenny Ahlstrom HealthTree Foundation
visit >BioSpace | 29 July 2022
GSK's 'Target the Future initiative' aims to improve multiple myeloma space for all
visit >PM Live | 1 July 2022
GSK announces The HealthTree Foundation’s multiple myeloma programme as first 'Think Tank' challenge winner
visit >PharmaShots | 23 February 2022
PharmaShots Interview: GSK’s Tania Small Shares Insight on Target the Future Program
visit >ConSalud | 19 January 2022
GSK launches 'Target the Future' to address the needs of multiple myeloma patients
visit >El Medico Interactivo | 18 January 2022
Target the Future addresses key challenges for multiple myeloma patients
visit >MM+M | 10 January 2022
GSK crowdsources multiple myeloma innovation in new program
visit >Myeloma Research News | 3 January 2022
GSK seeks ideas for improving life in myeloma community
visit >